A numerical study to investigate the impact of cell size of self-expanding aortic valve stents on paravalvular leakage

Abstract Transcatheter aortic valve replacement (TAVR) has become the standard treatment of multimorbid patients with severe aortic valve stenosis. One frequently observed complication after TAVR procedure is the occurence of paravalvular leakage (PVL). PVL is caused by a gap between the vessel wall and the TAVR stent, enabling blood to flow from the aorta back to the ventricle during diastolic phase. A high PVL rate leads to increased mortality of TAVR patients. To avoid this complication, pericardial skirts were developed by manufacturers to seal the leakage gap. Furthermore, the aim is to improve the conforming expansion of the TAVR stent to the vessel wall, especially for the self-expanding TAVR consisting of nitinol. One factor for the expansion is the size and shape of the TAVR stent cells, which vary between 9 and 15 cells in the circumferential direction for established TAVR devices. To quantify the impact of different cell sizes on the occurence of PVL, we performed numerical studies with different TAVR designs and investigated the PVL for each TAVR design. For this purpose, we developed three different TAVR designs with 9, 12 and 15 stent cells in the circumferential direction of the TAVR. These were deployed into a generic aortic root model with standardized calcification in the annulus region using finite element simulations. Afterwards, the PVL was calculated using numerical flow simulations. We found that the TAVR stent design with nine cells had the highest PVL rate (11.2mLs −1 ). In contrast, the TAVR stent design with 15 cells had the lowest PVL (4.8mLs −1 ). Our study thus showed a decisive impact of cell size on the sealing behavior of the TAVR stent and, accordingly, the PVL.

Authors

Institutions

Publication Details

Journal
Current Directions in Biomedical Engineering
Published
2024-12-01
DOI
https://doi.org/10.1515/cdbme-2024-2026
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A numerical study to investigate the impact of cell size of self-expanding aortic valve stents on paravalvular leakage

Finja Borowski, Sebastian Kaule, Michael Stiehm, Laura Supp et al.
Current Directions in Biomedical Engineering
Cardiac Valve Diseases and Treatments
article

A numerical study to investigate the impact of cell size of self-expanding aortic valve stents on paravalvular leakage

Finja Borowski, Sebastian Kaule, Michael Stiehm, Laura Supp, Klaus-Peter Schmitz, Jan Oldenburg, Alper Öner
article en

Abstract

Abstract Transcatheter aortic valve replacement (TAVR) has become the standard treatment of multimorbid patients with severe aortic valve stenosis. One frequently observed complication after TAVR procedure is the occurence of paravalvular leakage (PVL). PVL is caused by a gap between the vessel wall and the TAVR stent, enabling blood to flow from the aorta back to the ventricle during diastolic phase. A high PVL rate leads to increased mortality of TAVR patients. To avoid this complication, pericardial skirts were developed by manufacturers to seal the leakage gap. Furthermore, the aim is to improve the conforming expansion of the TAVR stent to the vessel wall, especially for the self-expanding TAVR consisting of nitinol. One factor for the expansion is the size and shape of the TAVR stent cells, which vary between 9 and 15 cells in the circumferential direction for established TAVR devices. To quantify the impact of different cell sizes on the occurence of PVL, we performed numerical studies with different TAVR designs and investigated the PVL for each TAVR design. For this purpose, we developed three different TAVR designs with 9, 12 and 15 stent cells in the circumferential direction of the TAVR. These were deployed into a generic aortic root model with standardized calcification in the annulus region using finite element simulations. Afterwards, the PVL was calculated using numerical flow simulations. We found that the TAVR stent design with nine cells had the highest PVL rate (11.2mLs −1 ). In contrast, the TAVR stent design with 15 cells had the lowest PVL (4.8mLs −1 ). Our study thus showed a decisive impact of cell size on the sealing behavior of the TAVR stent and, accordingly, the PVL.

Current Directions in Biomedical EngineeringVol. 10(4)
Institute for ImplantTechnology and Biomaterials (DE), University of Rostock (DE)
Openalex Percentile: Top 57%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.